The Novo Nordisk Foundation has awarded a grant of DKK 150 million—or roughly $21.8 million—to establish the Copenhagen Center for Biomedical Quantum Sensing, under which an international research collaboration will aim to develop novel quantum sensing principles and techniques for early detection of diseases. Under this new research project, researchers at the University of Copenhagen, the Technical University of Denmark and the University of Texas at Austin aim to advance quantum sensing and imaging technologies in medical diagnostics and healthcare. The primary goal of the new research collaboration is to develop and use novel quantum sensing principles and techniques for biomedical diagnostics that can operate near and beyond standard quantum limits of sensitivity, providing ultrasensitive platforms for early detection of disease and facilitating profound investigations into cellular systems at an unprecedented scale and precision, the foundation said.
The Novo Nordisk Foundation has awarded a grant of DKK 150 million—or roughly $21.8 million—to establish the Copenhagen Center for Biomedical Quantum Sensing, under which an international research collaboration will aim to develop novel quantum sensing principles and techniques for early detection of diseases. Under this new research project, researchers at the University of Copenhagen, the Technical University of Denmark and the University of Texas at Austin aim to advance quantum sensing and imaging technologies in medical diagnostics and healthcare. The primary goal of the new research collaboration is to develop and use novel quantum sensing principles and techniques for biomedical diagnostics that can operate near and beyond standard quantum limits of sensitivity, providing ultrasensitive platforms for early detection of disease and facilitating profound investigations into cellular systems at an unprecedented scale and precision, the foundation said.
This research explores how quantum physics is redefining the landscape of medical diagnostics through sensing, imaging, and computation. It examines the principles of quantum mechanics superposition, entanglement, and coherence and their application in developing technologies capable of detecting disease at molecular and cellular levels. Quantum imaging surpasses classical resolution limits, while quantum machine learning enables faster and more accurate analysis of medical data. The study also evaluates real-world clinical applications, including wearable magnetoencephalography, quantum-enhanced MRI, and biosensing for cancer biomarkers. Alongside these advancements, it addresses ethical, economic, and regulatory challenges such as data security, cost, and accessibility. The findings suggest that quantum technologies hold transformative potential to shift medicine from reactive treatment to predictive, preventive care provided innovation remains grounded in transparency, inclusivity, and interdisciplinary collaboration.
Artificial Intelligence (AI) is revolutionizing diagnostics by enhancing the capabilities of quantum imaging (QI) and quantum sensors (QS) in healthcare. By leveraging AI-driven algorithms, QI achieves superior image resolution, noise reduction, and real-time data analysis, enabling precise visualization of biological structures and early disease detection. AI’s pattern recognition capabilities facilitate the identification of subtle biomarkers and anomalies critical for diagnosing complex conditions, such as cancer and neurodegenerative diseases. Quantum mechanics underpins these advancements, driving breakthroughs in biosensing through quantum dots (QDs), plasmonic biosensors, and non-classical light, which enhance sensitivity and precision. Advanced techniques like quantum Raman spectroscopy and nitrogen-vacancy (NV) center-based sensors enable cutting-edge molecular detection and diagnostics applications. Furthermore, AI optimizes QS functionality, improving the accuracy of physiological and molecular measurements essential for non-invasive diagnostics. Integrating AI with QI systems reduces operational complexity, accelerates diagnostic workflows, and supports multimodal imaging approaches for comprehensive patient assessments. This review demonstrates the synergy between AI and quantum technologies, representing a transformative leap in medical diagnostics, offering unprecedented precision, speed, and accessibility for improved healthcare outcomes.
The convergence of quantum science and bioelectronics marks a new era in biomedical innovation, enabling unprecedented precision in sensing, imaging, and diagnostics. This book, Quantum Bioelectronics: Foundations, Technologies, and Applications, is designed to bridge the gap between quantum physics and biomedical engineering, providing a comprehensive understanding of how quantum principles can revolutionize healthcare technologies. Beginning with fundamental concepts, the book introduces the evolution of bioelectronics and the essential principles of quantum mechanics relevant to biological systems. It then explores the transformative role of quantum-enhanced imaging and sensing, presenting real-world case studies that demonstrate how these technologies are redefining disease detection, neural monitoring, and molecular analysis. A dedicated section addresses the integration of quantum devices with bioelectronic platforms, including lab-on-chip systems and AI-assisted hybrid architectures, highlighting their potential for personalized and portable healthcare. The later chapters discuss clinical and pharmaceutical applications, culminating in an insightful analysis of technological, ethical, and regulatory challenges. Through a structured and interdisciplinary approach, this volume serves as both a foundational reference and a visionary guide for researchers, engineers, and clinicians seeking to harness the power of quantum technologies in biomedical science. It is our hope that the ideas and insights presented herein will inspire further exploration and innovation toward a future where quantum bioelectronics transforms human health and well-being.
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, demanding innovations that transcend the limitations of conventional diagnostic modalities. Traditional imaging technologies—such as echocardiography, CT angiography, and MRI—though well-established, often struggle with trade-offs between speed, resolution, and predictive capabilities. Emerging advances in quantum science, particularly quantum computing1 and quantum sensing2, promise to redefine cardiac diagnostics by enabling unprecedented computational power, enhanced imaging fidelity, and predictive analytics. This paper explores the paradigm shift from traditional cardiac imaging to quantum-assisted diagnostics, emphasizing its transformative potential in precision cardiology. Quantum computing harnesses the principles of superposition3, entanglement4, and quantum tunneling5 to perform complex computations at speeds exponentially faster than classical systems. In cardiology, this capability translates into ultra-rapid analysis of massive multi-modal datasets—integrating genetic profiles, imaging scans, wearable sensor data, and electronic health records—to derive predictive risk scores and detect disease progression at its earliest molecular signatures. Quantum machine learning algorithms can identify subtle, non-linear patterns6 in cardiac pathophysiology that conventional statistical models fail to capture, thus enabling clinicians to anticipate adverse events such as arrhythmias, myocardial infarction, or heart failure with higher accuracy and lead time. Quantum sensing further enhances diagnostic precision through highly sensitive magnetometers and photon detectors, capable of mapping cardiac electrophysiology and microvascular changes at nanoscale resolution without invasive procedures. These innovations address current bottlenecks in traditional imaging—such as motion artifacts, limited temporal resolution, and radiation exposure—offering safer, faster, and more detailed diagnostic pathways. By coupling quantum sensors with real-time data processing, clinicians can monitor dynamic cardiac functions continuously, bridging the gap between snapshot diagnostics and continuous cardiovascular health tracking. This research paper presents a comparative analysis of traditional versus quantum-enabled cardiac diagnostics, highlighting the future potential of quantum technologies in cardiac detection and medical assistance. The study emphasizes advancements in imaging clarity, predictive accuracy, and clinical outcome improvement enabled by quantum approaches. A progressive implementation model is proposed, outlining how quantum-assisted systems can be integrated into existing hospital infrastructure through cloud-based quantum computing platforms, thereby reducing costs and minimizing operational disruptions. The paper explores regulatory, ethical, and training considerations essential for the medical community in adopting these emerging technologies. The paper shows that using quantum technology in heart disease diagnosis can make the process much faster and more accurate. This means doctors can plan treatments better and help reduce serious illness by detecting problems early. Quantum methods can also predict heart issues even before symptoms appear, making it possible to screen large groups of people at low cost and without painful tests. In the future, combining quantum-powered artificial intelligence (AI) with telemedicine could bring advanced heart care to people everywhere, especially in areas where hospitals and doctors are limited. In conclusion, combining quantum computing with heart care could bring a big change in how we treat heart diseases. Instead of waiting for problems to appear, doctors could use quantum tools to predict risks early and give more accurate treatments. This can help reduce heart disease worldwide. Even though there are challenges in making these technologies widely available, their potential is huge. This research shows why it is important to adopt such tools early, encourage new ideas, and work together so that patients can benefit from these advances in the near future.
In the years to come, quantum computing will find applications in different industries - from IT and finance to transportation. Within the medical industry, quantum technology has the potential to reduce the time it takes to develop new drugs as well as speed up the computationally demanding tasks of analysing and interpreting large amounts of biological data. The new Novo Nordisk Foundation Center Quantum for Life based at the University of Copenhagen has taken up this challenge. But new quantum hardware alone will not get us there. It will require the development of an entirely new type of software – quantum software.
The rapid advancements in technology and scientific research have led to an unprecedented demand for precise and reliable measurement systems. Traditional sensors, while highly effective in many domains, often face limitations in terms of sensitivity, accuracy, and environmental robustness. Unlike classical sensors, these devices offer unparalleled sensitivity and precision, enabling measurements of physical quantities such as magnetic fields, gravitational waves, and temperature with quantum-level accuracy. This study presents a comprehensive performance evaluation of various quantum sensing technologies for blood-based disease biomarker detection. Using simulation data from the Quantum Toolbox in Python (QuTiP), key performance metrics, including coherence time, signal-to-noise ratio, dynamic range, and entanglement, were analyzed across biomarkers. Results indicate that Quantum Coherence sensors exhibit superior diagnostic potential due to their high coherence and signal fidelity, followed by Atomic Magnetometers and Nitrogen vacancy Centers, which offer a balance between sensitivity and practical deployment. While Quantum Dots demonstrated strengths in resolution and entanglement, they were limited by noise susceptibility. Superconducting Quantum Interference Devices, despite their established reliability, showed reduced performance in critical quantum metrics. Bridging the gap between laboratory validation and clinical deployment will require interdisciplinary collaboration, standardization, and large-scale clinical trials.